
Microbot Medical MBOT
$ 1.8
0.0%
Quarterly report 2025-Q3
added 11-12-2025
Microbot Medical Total Shareholders Equity 2011-2026 | MBOT
Annual Total Shareholders Equity Microbot Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.5 M | 7.29 M | 14.4 M | 24.3 M | 31.5 M | 1.33 M | 9.96 M | 1.7 M | -64 K | 857 K | 375 K | 14 M | 10.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.5 M | -64 K | 9.3 M |
Quarterly Total Shareholders Equity Microbot Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.2 M | 30.4 M | 29 M | 3.53 M | 3.81 M | 6.06 M | 6.17 M | 4.5 M | 7.36 M | 9.47 M | 4.85 M | 7.29 M | 5.53 M | 8.54 M | 11.6 M | 14.4 M | 17.9 M | 20.1 M | 22.3 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | 31.5 M | 31.5 M | 31.5 M | 31.5 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 9.99 M | 9.96 M | 9.96 M | 9.96 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | -64 K | -334 K | -334 K | -334 K | 857 K | 5.87 M | 5.87 M | 5.87 M | 375 K | 15 M | 15 M | 15 M | 14 M | 14 M | 14 M | 14 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 78.2 M | -334 K | 12.3 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
Baxter International
BAX
|
6.96 B | $ 20.07 | - | $ 10.2 B | ||
|
Ekso Bionics Holdings
EKSO
|
12.7 M | $ 8.7 | - | $ 175 M | ||
|
ICU Medical
ICUI
|
1.97 B | $ 149.9 | - | $ 3.66 B | ||
|
Alcon
ALC
|
18.8 B | $ 80.98 | - | $ 40.4 B | ||
|
InfuSystem Holdings
INFU
|
48 M | $ 8.26 | - | $ 171 M | ||
|
AtriCure
ATRC
|
461 M | $ 36.93 | - | $ 1.73 B | ||
|
electroCore
ECOR
|
7.44 M | $ 6.66 | -6.2 % | $ 36.7 K | ||
|
Haemonetics Corporation
HAE
|
821 M | $ 66.66 | - | $ 3.35 B | ||
|
AngioDynamics
ANGO
|
183 M | $ 10.36 | - | $ 423 M | ||
|
The Cooper Companies
COO
|
8.24 B | $ 81.38 | 1.26 % | $ 16.2 B | ||
|
Harvard Bioscience
HBIO
|
73.1 M | $ 0.5 | -6.65 % | $ 21.2 M | ||
|
Merit Medical Systems
MMSI
|
1.38 B | $ 81.09 | - | $ 4.72 B | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 119.38 | - | $ 5.78 B | ||
|
Isoray
ISR
|
291 M | - | 0.03 % | $ 108 M | ||
|
Repro Med Systems
KRMD
|
20.4 M | $ 5.39 | -1.1 % | $ 246 M | ||
|
OraSure Technologies
OSUR
|
410 M | $ 2.79 | - | $ 208 M | ||
|
iRhythm Technologies
IRTC
|
90.9 M | $ 154.51 | 3.7 % | $ 4.82 B | ||
|
LeMaitre Vascular
LMAT
|
337 M | $ 84.97 | - | $ 1.91 B | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 137.33 | - | $ 7.32 B | ||
|
Intuitive Surgical
ISRG
|
16.4 B | $ 504.22 | - | $ 179 B | ||
|
STERIS plc
STE
|
6.6 B | $ 262.6 | - | $ 25.9 B | ||
|
Nephros
NEPH
|
8.36 M | $ 4.31 | -1.82 % | $ 44.8 M | ||
|
Milestone Scientific
MLSS
|
5.83 M | $ 0.28 | - | $ 22.3 M | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
Utah Medical Products
UTMD
|
128 M | $ 61.06 | - | $ 222 M | ||
|
Envista Holdings Corporation
NVST
|
2.93 B | $ 23.47 | - | $ 4.04 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.94 B | $ 12.47 | - | $ 2.53 B | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 39.23 | -0.44 % | $ 129 M | ||
|
Predictive Oncology
POAI
|
-203 K | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
44.4 M | $ 13.83 | - | $ 664 M | ||
|
Becton, Dickinson and Company
BDX
|
25.4 B | $ 203.48 | - | $ 58.5 B | ||
|
Repligen Corporation
RGEN
|
1.96 B | $ 149.37 | - | $ 8.32 M | ||
|
ResMed
RMD
|
3.36 B | $ 258.31 | 0.27 % | $ 37.7 B | ||
|
BioLife Solutions
BLFS
|
349 M | $ 21.8 | - | $ 1 B | ||
|
Stereotaxis
STXS
|
16.3 M | $ 2.19 | -6.01 % | $ 177 M | ||
|
Retractable Technologies
RVP
|
87.2 M | $ 0.7 | - | $ 21 M | ||
|
STAAR Surgical Company
STAA
|
397 M | $ 18.95 | - | $ 931 M | ||
|
Teleflex Incorporated
TFX
|
4.28 B | $ 104.37 | - | $ 4.89 B | ||
|
West Pharmaceutical Services
WST
|
2.68 B | $ 231.12 | - | $ 16.9 B |